Announcement on Voluntary Disclosure of Obtaining Approval of Clinical Trial for Split-Virion Influenza Vaccine (BK-01 Adjuvant)

About this update from Changchun Bcht Biotechnology Co. Class A

Announcement on Voluntary Disclosure of Obtaining Approval of Clinical Trial for Split-Virion Influenza Vaccine (BK-01 Adjuvant)The abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Changchun Bcht Biotechnology Co. Class A